- VNDA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Vanda Pharmaceuticals (VNDA) 10-K/A2014 FY Annual report (amended)
Filed: 10 Jun 15, 12:00am
EXHIBIT 31.3
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Mihael H. Polymeropoulos, certify that:
1. | I have reviewed this Amendment No. 1 on Form 10-K/A of Vanda Pharmaceuticals Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
June 10, 2015 | /s/ Mihael H. Polymeropoulos, M.D. | |
Mihael H. Polymeropoulos, M.D. | ||
President and Chief Executive Officer | ||
(Principal Executive Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.